Re: Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer

著录项

• 来源
  《Journal of the National Cancer Institute》 |2012年第9期|p.717-718|共2页
• 作者

  Robert C. Kane;

  展开▼
• 作者单位

  The views expressed are those of the author and should not be considered as representing the views of any other entity Affiliation of author: Division of Hematology Products, Office of Hematology Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词